PETROS PHARMACEUTICALS INC (PTPI) Stock Analyst Ratings
NASDAQ:PTPI - Nasdaq - US71678J2096 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to PTPI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.02. This target is 218.75% above the current price.
PTPI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PTPI.
In the previous month the buy percentage consensus was at a similar level.
PTPI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-08 | Maxim Group | Initiate | Buy |